RNA Viruses and Lymphocyte Immune Functions

  • L. Gazzolo
  • M. Duc Dodon
  • A. Gessain
  • M. Robert-Guroff
  • G. de-The
Part of the Experimental Biology and Medicine book series (EBAM, volume 11)


Among the diverse strategies used by viruses to induce human disease, their ability to cause immune defects has received increasing attention, concurrently with the identification of cells able to mount a large variety of immune responses and secrete numerous factors modulating these responses. In vivo, immunological dysfunctions may result from viral infections and be responsible for acute and/or chronic disorders. In vitro studies have documented the interactions between human lymphocytes and viruses, through which viral infections lead to an aberrant control of immune responses, and to subsequent diseases.


Chronic Lymphocytic Leukemia Sickle Cell Anemia Measle Virus Bovine Leukemia Virus Sickle Cell Anemia Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Robert-Guroff, M., Sarngadharan, M.G. & Gallo, R.C. (1984) In Growth and maturation factors, vol. 2, ed. Guroff, G., (J. Wiley & Sons, New York), pp. 267–308.Google Scholar
  2. 2.
    Melchers, F. & Andersson, J. (1984) Cell 37, 715–720.CrossRefGoogle Scholar
  3. 3.
    Smith, K.A. (1984) In Fundamental Immunology, ed. Paul, W.E. (Raven Press, New York), pp. 559–576.Google Scholar
  4. 4.
    Whittle, H.C., Dossetor, J., Oduloju, A., Bryceson, D.M. & Greenwood, B.M. (1978) J. Clin. Invest. 62, 678–687.PubMedCrossRefGoogle Scholar
  5. 5.
    Wilson, A.B., Planterose, D.N., Nagington, J., Park, J.R., Barry,R.D., & Coombs, R.R.A. (1976) Nature 259, 582–284.PubMedCrossRefGoogle Scholar
  6. 6.
    Sullivan, J.L., Barry, R.W., Lucas, S.J., & Albrecht, P. (1975) J. Exp. Med. 142, 773–784.PubMedCrossRefGoogle Scholar
  7. 7.
    Jacobson, S. & McFarland, H. (1982) J. Gen. Virol. 63, 351–357.PubMedCrossRefGoogle Scholar
  8. 8.
    Casal, P., Rice, G.P.A. & Olstone, M.B.A. (1984) J. Exp. Med. 159, 1322–1337.CrossRefGoogle Scholar
  9. 9.
    Duc Dodon, M., Gazzolo, L., Quash, G.A. & Wild, F.W. (1982) J. Gen. Virol. 63, 441–450.CrossRefGoogle Scholar
  10. 10.
    Duc Dodon M. & Quash, G.A. (1981) Immunology 42, 401–408.PubMedGoogle Scholar
  11. 11.
    Duc Dodon, M., Gazzolo, L. & Quash, G.A. (1984) Immunology 52, 291–297.PubMedGoogle Scholar
  12. 12.
    Galloway, G., Leung, A.Y.T., Hunneyball, I.M. & Stanworth, D.R. (1983) Immunology 49, 511–519.PubMedGoogle Scholar
  13. 13.
    Gallo, R.C. (1984) Cancer Surveys 3, 114–159.Google Scholar
  14. 14.
    Hardy, W.D., Jr., (1984) In Human T-cell leukemia/lymphoma virus, eds. Gallo, R.C., Essex, M.E. & Gross, L. (Cold Spring Harbor Laboratory) pp. 35–43.Google Scholar
  15. 15.
    Burny, A., Bruck, C., Couez, D. Deschamps, J., Ghysdael, J., Kettman, R., Mammerickx, M., Marbaix, G. & Portetelle, D. (1984) In Human t-cell leukemia/lymphoma virus, eds. Gallo, R.C., Essex, M.E. & Gross, L. (Cold Spring harbor Laboratory) pp. 17–24.Google Scholar
  16. 16.
    Papovic, M., Sarngadharan, M.G., Read, E. & Gallo, R.C. (1984) Science 224, 497–500.CrossRefGoogle Scholar
  17. 17.
    Barré-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., Rozenbaum, W. & Montagnier, L. (1984) Science 220, 868–870.CrossRefGoogle Scholar
  18. 18.
    Lane, H.C., Masur, H., Edgar, L.C., Whalen, G. & Fauci, A.S. (1983) N. Eng. J. Med. 309, 453–458.CrossRefGoogle Scholar
  19. 19.
    Siegal, F.P. (1984) Seminars in Oncology 11, 29–39.PubMedGoogle Scholar
  20. 20.
    Waldmann, T.A., Greene, W.C., Sarin, P.S., Saxinger, C., Blayney, D.W., Blattner, W.A., Goldman, C.K., Bongiovanni, K., Sharrow, S., Depper, J.M., Leonard, W., Uchiyama, T. & Gallo, R.C. (1984) J. Clin. Invest. 73 1711–1718.PubMedCrossRefGoogle Scholar
  21. 21.
    Mann, D.L., Clark, J., Clarke, M., Reitz, M., Popovic, M., Fanchini, G., Trainoir, C.D., Strong, D.M., Blattner, W.A., & Gallo, R.C. (1984) J. Clin. Invest. 74 56–62.PubMedCrossRefGoogle Scholar
  22. 22.
    Ongo, D.L., Gelmann, E.P., Cossman, J., Young, R.A., Gallo, R.C., O’Brien, S.J. & Matis, L.A. (1984) Nature 310, 505–506.CrossRefGoogle Scholar
  23. 23.
    Markham, P.D., Salahuddin S.Z., & Gallo, R.C. (1984) Clinics in Haematology 13, 423–446.PubMedGoogle Scholar
  24. 24.
    Gessain, A., Jouanelle, A., Escarment, P., Calender, A., Schaffar-Deshayes, L. & de-Thé, G. (1984) Lance, i, 1183–1184.CrossRefGoogle Scholar
  25. 25.
    Gessain, A., Gazzolo, L., Yoyo, M., Fortier, L., Robert-Guroff, M. & de-Thé, G. (1984) Lancet, submitted for publication.Google Scholar
  26. 26.
    Gessain, A., Calender, A., Strobel, M., Lefait-Robin, R. & de-The (1984) C.R. Acad. Sci. (Paris), in press.Google Scholar
  27. 27.
    Premier forum d’immunologic (1984) Ann. Immunol. 135C, 261–302Google Scholar

Copyright information

© The Humana Press Inc. 1985

Authors and Affiliations

  • L. Gazzolo
    • 1
  • M. Duc Dodon
    • 2
  • A. Gessain
    • 1
  • M. Robert-Guroff
    • 3
  • G. de-The
    • 1
  1. 1.Laboratoire d’Epidémiologie et d’Immunovirologie des Tumeurs (CNRS)Faculté de Médicine Alexis CarrelLyon Cédex 8France
  2. 2.Unité de Virologie (INSERM)Lyon Cédex 8France
  3. 3.Laboratory of Tumor Cell BiologyNational Cancer InstituteBethesdaUSA

Personalised recommendations